Bausch Health Q1 2022 Earnings Report
Key Takeaways
Bausch Health Companies Inc. announced its first-quarter 2022 financial results. The company reported revenues of $1.918 billion and a GAAP net loss of $69 million. Adjusted EBITDA was $732 million. Bausch + Lomb commenced trading under the ticker "BLCO" following its IPO.
Revenues of $1.918 Billion
GAAP Net Loss of $69 Million
Adjusted EBITDA (non-GAAP) of $732 Million
Bausch + Lomb Commenced Trading Under “BLCO” Ticker Following IPO
Bausch Health
Bausch Health
Bausch Health Revenue by Segment
Forward Guidance
Bausch Health updated its guidance for the full year of 2022 as follows: Full-Year revenue range of $8.25 – $8.40 billion, reaffirming organic growth of 3 – 5%. Full-Year Adjusted EBITDA (non-GAAP) range of $3.225 – $3.375 billion, including $100 million of the previously disclosed $150 million annual run rate of dis-synergies
Revenue & Expenses
Visualization of income flow from segment revenue to net income